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Abstract
Background: Epidural fibrosis is a common complication after laminectomy. It is associated with intractable lower
back pain and additional complications. To date, no study has evaluated whether the local application of rapamycin
(RAPA) can inhibit fibroblast proliferation and reduce epidural scar adhesion after laminectomy. The results of the
present study showed that the local application of RAPA reduces epidural fibrosis after laminectomy in rats.
Methods: In this study, 32 male Sprague-Dawley rats were randomly divided into four groups (0.2 mg/ml
RAPA-treated group, 0.1 mg/ml RAPA-treated group, 0.05 mg/ml RAPA-treated group and physiological saline
group). Laminectomy was performed at the level of lumbar segment 1 to 2, and different concentrations of
RAPA or saline were applied to the laminectomy sites for 10 min. Four weeks after laminectomy, the rats were
sacrificed, and the degrees of epidural adhesion in each group were evaluated. Macroscopic assessment,
analysis of hydroxyproline content, and histological analysis were used to determine the therapeutic effect of
the local application of RAPA on the inhibition of fibroblast proliferation and the reduction of epidural fibrosis
after laminectomy. Next, we cultured fibroblasts from epidural scar tissues of rats that had undergone laminectomy.
Fibroblasts were exposed to the indicated concentrations of RAPA, and western blotting and TUNEL assays were used
to assess the effects of RAPA on inhibiting fibroblasts proliferation and promoting fibroblast apoptosis.
Results: The results of macroscopic assessments, analysis of hydroxyproline content, and histological analyses indicated
that RAPA significantly inhibited fibroblast proliferation and reduced epidural fibrosis in the treated groups in the rat
model. The western blotting results indicated that the expression levels of the pro-apoptotic proteins cleaved-PARP
and Bax were up-regulated, whereas those of Bcl-2 were reduced. TUNEL assay indicated that the apoptosis rates of
fibroblasts were significantly increased after exposure to the indicated concentrations of RAPA.
Conclusions: The local application of RAPA reduced epidural fibrosis after laminectomy by inhibiting the proliferation
of fibroblasts, stimulating their apoptosis, and decreasing collagen synthesis. This protocol may be used in new clinical
treatment strategies to reduce epidural fibrosis after laminectomy.
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Background
Extensive epidural fibrosis is a troublesome complica-
tion after laminectomy. It can cause various clinical
conditions, such as failed back pain surgery syndrome
(FBSS), which is characterized by chronic radicular
nerve or lower back pain [1–3]. These types of compli-
cations make revision surgeries more complex and
time-consuming, and the results of reoperation are
often poor [4, 5]. Therefore, a solution to this problem
is greatly needed.
Many studies have explored ways to prevent epidural
scar adhesion after laminectomy. Many types of bio-
logical and synthetic materials, such as polymethyl
methacrylate, polylactic acid, autologous leather, silas-
tic silicone, and fat grafts, have shown anti-fibrotic ef-
fects [6–10]. Pharmaceutical agents, such as mitomycin
C, hydroxycamptothecine, colchicine, steroid hormone
and anti-inflammatory agents, have been used to reduce
epidural fibrosis [11–14]. However, limited or variable
success has been achieved, and some medicines cause side
effects such as wound infection. Therefore, it is still
clinically urgent to explore new methods for reducing
epidural fibrosis. Recently, it has been reported that
macrolide antibiotics, such as azithromycin and tacroli-
mus (FK506), exhibit effectiveness in reducing the fi-
brosis of epidural scars [13, 15].
RAPA, also called sirolimus, is a type of macrolide
antibiotic and immunosuppressive agent [16–18]. Ani-
mal studies and clinical trials have shown that it has
low renal toxicity and good effectiveness. It is widely
used to prevent transplantation rejection [19, 20]. Many
studies have indicated that RAPA is effective in inhibit-
ing scar adhesion. In ophthalmology, the local applica-
tion of RAPA is used to prevent scar adhesion after
cataract surgery [21–24]. Studies on pathological scars
have indicated that RAPA inhibits the proliferation of
fibroblasts [25–27]. However, no study has determined
whether the local application of RAPA can reduce epi-
dural fibrosis after laminectomy.
In the present study, we sought to evaluate the thera-
peutic effect of local application of RAPA on inhibiting
fibroblast proliferation and reducing epidural fibrosis.
The results of this study may provide a novel method to
reduce the adhesion of epidural scars, which may be use-
ful in future human trials for clinical applications.
Methods
Animals, cells and reagents
Thirty-two healthy male Sprague-Dawley rats (mean
weight of 350 g) were purchased from Shanghai Labora-
tory Animal Center. The animals received care in com-
pliance with the principles of International Laboratory
Animal Care, and the experimental protocol was ap-
proved by the Animal Care and Research Committee of
Yang Zhou University (Yangzhou, China). RAPA, which
was purchased from Astellas Ireland Co, Ltd. (Killorhlin,
Co. Kerry, Ireland), was dissolved in dimethyl sulfoxide
(DMSO) purchased from Sigma-Aldrich (St Louis, MO,
USA) and stored at −20 °C. The RAPA solution was di-
luted with saline or cell culture medium such that the
DMSO comprised < 0.1%. Specific antibodies against
cleaved-PARP, Bcl-2 and Bax were purchased from Cell
Signaling Technology (Cambridge, MA, USA). All rats
were randomly divided into four groups (eight rats in
each group): 0.05 mg/ml RAPA, 0.1 mg/ml RAPA,
0.2 mg/ml RAPA, and saline groups. Before the experi-
ment, the rats were housed for 1 week and allowed to
adapt to the conditions of the laboratory.
A primary fibroblast cell line was cultured from the
epidural scar tissue of rats that had undergone lamin-
ectomies. Briefly, the scar tissues at L1–L2 level were
anatomically separated and rinsed immediately with
phosphate-buffered saline, then cut into 1 × 1 mm2 sec-
tions and cultured in Dulbecco’s modified Eagle’s
medium (DMEM; Invitrogen, CA, USA) supplemented
with 10 % foetal bovine serum, 0.1 U/l penicillin, and
50 μg/ml streptomycin (Gibco, CA, USA) at 37 °C in
5 % CO2. Culture media were replaced every 2 days
until fibroblasts reached approximately 80 % confluence.
The cells of passages 3 to 6 were used in all experiments,
the cells were transfered into a serum-free medium over-
night and then subjected to various reagent treatments
with varying doses of RAPA, as indicated in the figure
legends.
All other reagents were purchased from Sigma Aldrich
(St Louis, MO, USA) unless stated otherwise.
Construction of the laminectomy model
A rat laminectomy model was used to determine the ef-
fects of RAPA on epidural fibrosis. Briefly, each rat was
anaesthetized with an intraperitoneal injection of 1 %
pentobarbital sodium solution (4 ml/kg body weight)
and then fixed in the prone position. The animal’s back
hair at the level of L1 and L2 was shaved, and skin was
sterilized with iodophor three times. The laminectomy
model was constructed according to methods described
in previous studies [28, 29]. All procedures were per-
formed under sterile conditions with basic surgical tools,
surgical microscopes and an electrical drill. A median in-
cision of the dorsal skin at the level of L1–L2 was made,
and the paraspinal muscles were separated. A rongeur
was used to remove the spinous process and vertebral
plate, and the dura mater at the L1 to L2 level was ex-
posed. Then, cotton soaked with different concentra-
tions of RAPA (0.05 mg/ml, 0.1 mg/ml and 0.2 mg/ml)
or saline was applied to the surgical site for 10 min (the
volume of application was approximately 1 ml). The
surrounding tissues were protected from contact with
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the agent. Satisfactory haemostasis was achieved by
using gauze; bone wax and cauterization after laminec-
tomy were not needed. All procedures were performed
with care to avoid injury to the neural tissues.
Macroscopic assessment of epidural fibrosis
Four weeks after the surgery, four rats in each group
were randomly selected, and the surgical sites were reo-
pened carefully. The degree of epidural fibrosis at the L1
to L2 level was evaluated by three professional blinded
pathologists according to the Rydell classification [30]
(grade 0 = epidural scar tissue was not adherent to the
dura mater; grade 1 = epidural scar tissue was adherent
to the dura mater but was easily dissected; grade 2 = epi-
dural scar tissue was adherent to the dura mater and
was difficult to dissect without disrupting the dura
mater; and grade 3 = epidural scar tissue was firmly ad-
herent to the dura mater and could not be dissected).
Hydroxyproline content analysis
After macroscopic assessment of epidural fibrosis, the
scar tissue (wet weight = approximately 4 mg) was col-
lected from L1 to L2 area surrounding the laminectomy
site. The content of hydroxyproline in the scar tissue of
different groups was determined according to the
methods described in previous study [31, 32]. Briefly,
the samples were lyophilized, ground and hydrolysed
with 6 mol/l HCl at 130 °C for 12 h separately. The
samples were then neutralized with 2.5 N NaOH with
methyl red as an indicator. Chloramine T (1 ml) was
added to the hydrolysed samples along with four hy-
droxyproline standards of known concentrations. After
incubation for 20 min at room temperature, the hydroxy-
proline developer was added to the samples and standards.
The absorbance of the solution was measured at 558 nm
with a spectrophotometer, and the hydroxyproline content
per milligram of scar tissue was calculated according to
the standard curve, which was constructed with serial
concentrations of commercial hydroxyproline.
Histological analysis
Four rats randomly selected from each group were sacri-
ficed after 4 weeks for histological evaluation. The entire
L1–L2 spine column, including the paraspinal muscles
and epidural scar tissues, was collected and immersed in
10 % buffered formalin for 5 days. The specimens were
decalcified in 10 % EDTA (Sigma Aldrich, St Louis, MO,
USA) for 3 weeks and embedded in paraffin. Then, 4-
mm transverse sections were made through the L1–L2
vertebra, and this was followed by staining with haema-
toxylin–eosin (HE) and Masson’s trichrome. Three
counting areas (100 × 100 μm each) were selected at the
middle and at the margins of the laminectomy sites, and
the number of fibroblasts was calculated.
Analysis of RAPA’s influence on the proliferation of
fibroblasts
To further determine the effects of RAPA on the prolif-
eration of fibroblasts, the fibroblasts were cultured in
Dulbecco’s modified Eagle’s medium (DMEM; Invitro-
gen, CA, USA) supplemented with 10 % foetal bovine
serum, 0.1 U/l penicillin, and 50 μg/ml streptomycin
(Gibco, CA, USA) at 37 °C and 5 % CO2. Briefly, fibro-
blasts were plated in six-well plates at a density of 8 × 105
cells/well and cultured in Dulbecco’s modified Eagle’s
medium (DMEM; Invitrogen, CA, USA) supplemented
with 10 % foetal bovine serum, 0.1 U/l penicillin, and
50 μg/ml streptomycin (Gibco, CA, USA) at 37 °C in 5 %
CO2. After reaching approximately 80 % confluence, the
cells were transferred into serum-free medium over-
night and then subjected to treatment with different
concentrations of RAPA (0, 0.01, 0.1, and 1 μg/ml) for
48 h, as indicated in the figure legends. Then, the num-
ber of fibroblasts and changes in cell morphology were
observed under a light microscope.
Western blotting analysis of apoptosis markers
To further determine the effect of RAPA on the expres-
sion of apoptotic proteins, such as cleaved-PARP, Bax,
and Bcl-2, fibroblasts were seeded in six-well plates at a
density of 5 × 105 and cultured in DMEM supplemented
with 10 % foetal bovine serum and 1 % penicillin. When
the cells were confluent, they were transfered into
serum-free medium overnight and then pre-treated with
or without different concentrations of RAPA for 48 h.
Then, total proteins were extracted from cultured cells
using radioimmuno-precipitation assay (RIPA) lysis buf-
fer (Sigma-Aldrich, St Louis, MO, USA). Protein con-
centrations were determined using a bicinchoninic acid
assay (BCA; ThermoFisher, MA, USA). Thirty micro-
grams of each protein lysate was added to each lane and
resolved using sodium dodecyl sulphate-polyacrylamide
gel electrophoresis (SDS-PAGE, Sigma Aldrich, St Louis,
MO, USA) on 12 or 6 % gels and transferred to polyvi-
nylidene difluoride membranes (Millipore, Bedford, MA,
USA). The primary antibodies were diluted in 1 % (w/v)
skimmed milk powder in TBS-Tween and incubated
overnight at 4 °C. Membranes were then washed and in-
cubated with the appropriate secondary antibodies conju-
gated with IRDye 800CW (molecular weight = 1162 Da).
Antibody reactivity was detected after exposure in an
Odyssey infrared imaging system (LI-COR, Nebraska,
USA).All the experiments were repeated three times.
TUNEL assay in cultured fibroblasts
To evaluate the apoptotic rate of RAPA on fibroblasts,
the cells were transferred into a serum-free medium
overnight and then pre-treated with or without different
concentrations of RAPA for 48 h, the apoptotic rate of
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fibroblasts was analysed using a TdT-mediated dUTP-
biotin nick-end labelling (TUNEL) test system (Roche,
USA) according to the manufacturer’s instructions. Fol-
lowing staining, the apoptotic features of cell death were
examined via fluorescence microscopy. The obtained im-
ages were merged and analysed using Image J software.
The percentage of TUNEL-positive cells was defined as
the number of TUNEL-stained cells divided by the num-
ber of DAPI-stained cells. The cells were counted by a
naive observer.
Statistical analysis
The statistical analysis was performed with SPSS software
(version 19.0). The results of the data were expressed as
the means ± standard deviation. P values < 0.05 were con-
sidered statistically significant.
Results
Macroscopic assessment of epidural fibrosis
The surgery was well tolerated by all rats, without the
occurrence of wound infection, neurological deficits or
cerebrospinal leaks. The results of macroscopic observa-
tion indicated that soft or weak scar adhesion was found
in the 0.2 mg/ml RAPA group. Moderate scar adhesion
was seen in the 0.1 mg/ml RAPA group; the tissues
could be dissected by manual traction with less bleeding.
However, severe epidural adhesions were observed in
both the 0.05 mg/ml RAPA group and control group;
dissection of the scar tissue was difficult and was accom-
panied by bleeding and disruption of the dura mater.
The levels of epidural fibrosis were evaluated according
to the Rydell classification, and the results are shown in
Table 1.
Histological analysis
The typical images of HE staining and masson staining
of epidural scar tissues at L1–L2 levels were shown in
Figs. 1 and 2, respectively. In both the control group and
the 0.05 mg/ml RAPA group, dense epidural scar tissue
and compact collagen tissues were found in the laminec-
tomy sites, and the scar tissues were widely adhered to
the dura mater and dorsal muscle (Figs. 1d and 2d;
Figs. 1c and 2c). Moderate epidural scar adhesion and
collagen tissues were found in the 0.1 mg/ml RAPA
group (Figs. 1b and 2b). However, loose scar adhesion
and collagen tissues were formed in the 0.2 mg/ml
RAPA group (Figs. 1a and 2a).
Hydroxyproline content analysis
The hydroxyproline content of epidural scar tissue is
shown in Fig. 3. The hydroxyproline content of the
0.2 mg/ml RAPA group was 33.08 ± 2.23 μg/mg, which
was significantly lower than those of the 0.1 mg/ml
RAPA group (43.39 ± 2.01 μg/mg), the 0.05 mg/ml
RAPA group (55.08 ± 1.41 μg/mg) and the control group
(58.14 ± 3.19 μg/mg) (#p < 0.05). The hydroxyproline
content of the 0.1 mg/ml RAPA group was also lower
than those of the 0.05 mg/ml RAPA group and the con-
trol group (*p < 0.05). However, there was no significant
difference between the 0.05 mg/ml RAPA group and the
control group (p = 0.203).
Effect of RAPA on fibroblasts in epidural scar tissues
The fibroblasts of epidural scar tissue and fibroblast
counts in each group are shown in Figs. 4 and 5, respect-
ively. The fibroblast counts were 19 ± 2.65 in the 0.2 mg/
ml RAPA group, 34.67 ± 2.52 in the 0.1 mg/ml RAPA
group, and 50.33 ± 2.08 in the 0.05 mg/ml RAPA group.
The 0.2 mg/ml RAPA group and the 0.1 mg/ml RAPA
Table 1 The grade of epidural scar adhesion through macroscopic
was evaluated in rats according to the Rydell standard
Group Grade
0 1 2 3
Saline 0 0 0 4
0.05 mg/ml 0 0 1 3
0.1 mg/ml 0 3 1 0
0.2 mg/ml 3 1 0 0
Four rats were randomly selected from the RAPA-treated groups of different
concentrations and saline group
Fig. 1 Photomicrographs of the epidural adhesions at the laminectomy
sites from groups treated with 0.2 mg/ml RAPA (a), 0.1 mg/ml RAPA (b),
0.05 mg/ml RAPA (c) and the control group (d). Loose scar tissues
(asterisk) with little adherence to the dura mater (arrow) were
found in the 0.2 mg/ml RAPA group (a). Moderate scar tissues
(asterisk) were found in the 0.1 mg/ml RAPA group (b). However,
dense scar tissues (asterisks) adhered to the dura mater (arrow)
were found in the 0.05 mg/ml RAPA (c) group and the control
group (d). “S” represents the spinal cord. The sections were stained
with haematoxylin–eosin. The magnification was ×200
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group showed significantly lower fibroblast counts than
the control group (54.67 ± 3.21) (*p < 0.05), but there
was no significant difference between the 0.05 mg/ml
RAPA group and the control group (p = 0.122). The
number of fibroblasts in the 0.2 mg/ml RAPA groups
was also significantly lower than those of the other
RAPA groups (#p < 0.05).
Effects of RAPA on the proliferation and apoptosis of
fibroblasts
As shown in Fig. 6, after fibroblasts were transfered into
serum-free medium overnight and treated with different
concentrations of RAPA (0, 0.01, 0.1, and 1 μg/ml) for
48 h, the proliferation of fibroblasts was clearly inhib-
ited. The number of fibroblasts decreased with increas-
ing doses of RAPA.
Fig. 2 The effect of RAPA on collagen density in epidural adhesion
issues in the laminectomy sites in groups treated with 0.2 mg/ml
RAPA (a), 0.1 mg/ml RAPA (b), 0.05 mg/ml RAPA (c) or the control
group (d). Collagen tissue is shown in blue because the sections are
stained with Masson’s trichrome. The density of collagen in the
sections from the 0.2 mg/ml RAPA-treated group (a) was clearly
lower than that in tissue samples from the 0.1 mg/ml RAPA (b) and
0.05 mg/ml RAPA (c) groups and the control group (d). “S” represents
the spinal cord. “*” represents the scar adhesion area of epidural. The
sections were stained with masson. The magnification was ×100
Fig. 3 The effect of RAPA on the hydroxyproline content of epidural
scar tissue in each group. Hydroxyproline levels (μg/mg) in epidural
scar tissues of rats after treatment with different concentrations of
RAPA and the control group were evaluated. *p < 0.05 versus the
control group. #p < 0.05 in the 0.2 mg/ml RAPA group compared to
the other RAPA groups
Fig. 4 Histological observation of fibroblasts in the epidural scar
tissue of the laminectomy defect areas in groups treated with RAPA
of 0.2 mg/ml (a), 0.1 mg/ml (b), 0.05 mg/ml (c) or the control
group(d). The number of fibroblasts in the 0.2 mg/ml RAPA group
and 0.1 mg/ml RAPA group was lower than in the control group,
but there was no significant difference between the 0.05 mg/ml
RAPA group and control group. The fibroblast count in the 0.2 mg/
ml RAPA group was also lower than those of the other RAPA
groups. The sections were stained with haematoxylin–eosin and
the magnification is ×400
Fig. 5 The numbers of fibroblasts in groups treated with different
concentrations of RAPA (0.2 mg/ml, 0.1 mg/ml, 0.05 mg/ml) and the
control group. *p < 0.05 compared to the control group. #p < 0.05 in
the 0.2 mg/ml RAPA group compared to the 0.1 mg/ml RAPA group
and 0.05 mg/ml RAPA group
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To evaluate the effect of RAPA on the apoptosis of fi-
broblasts, western blotting was used to determine the
expression of the pro-apoptotic proteins cleaved-PARP
and Bax and the anti-apoptotic protein Bcl-2 after fibro-
blasts were treated with different concentrations of
RAPA. With increasing doses of RAPA, the expression
levels of cleaved-PARP and Bax increased. However, the
expression level of the anti-apoptotic protein Bcl-2 de-
creased. The results are shown in Fig. 7.
As shown in Fig. 8, the results of the TUNEL assay in-
dicated that few apoptotic fibroblasts were found in the
control group. After fibroblasts were treated with differ-
ent concentrations of RAPA, the number of apoptotic fi-
broblasts increased. As shown in Fig. 9, compared with
those of the control group, the rates of TUNEL-positive
cells increased significantly in the fibroblasts of RAPA-
treated groups (*p < 0.05).
Discussion
Currently, the exact mechanisms that underlie the devel-
opment of epidural fibrosis after laminectomy are still
uncertain. It has been found that immune and inflam-
matory reactions play key roles in the formation of epi-
dural fibrosis [33, 34]. After being stimulated by various
immune cytokines, fibroblasts tend to proliferate exten-
sively, produce collagen, and release extracellular matrix,
which ultimately results in the formation of epidural scar
adhesion. Excessive scar tissues tend to adhere to the
dura mater or nerve roots in the vertebral canal, thus
resulting in nerve root entrapment and limited nerve
root mobility. Therefore, pharmaceutical agents that in-
hibit immune and inflammatory reactions and thus in-
hibit the proliferation of fibroblasts may be effective in
reducing epidural scar adhesion.
RAPA is a new type of immunosuppressive drug
characterized by a better clinical effect, low toxicity,
and no renal toxicity (Fig. 9). Currently, RAPA is
widely used to prevent the acute rejection of allograft
transplants and suppress tumour growth [35, 36].
Many studies have shown that RAPA has anti-fibrosis
properties. It has been found that 0.01 to 1 μg/ml
RAPA inhibits the expression of MMP-1 and collagen
in fibroblasts [37]. RAPA also suppresses the prolifera-
tion of fibroblasts. Additionally, the placement of a
biodegradable rapamycin-eluting nano-fibre membrane-
covered metal stent reduces fibroblast proliferation in
experimental strictures in a canine model [38].
In this study, we cultured fibroblasts from the epi-
dural scar tissues of rats after laminectomy and ex-
posed the cells to various concentrations of RAPA.
After fibroblasts were cultured with different concen-
trations of RAPA (0, 0.01, 0.1, and 1 μg/ml) for 48 h,
the proliferation of fibroblasts was markedly inhibited.
The number of fibroblasts decreased with increases in
the concentration of RAPA. The western blotting re-
sults indicated that RAPA promoted the expression of
pro-apoptotic proteins, such as Bax and cleaved-PARP,
whereas it inhibited the expression of the anti-
apoptotic protein Bcl-2 in fibroblasts. The results of the
TUNEL assay indicated that RAPA promoted the apop-
tosis of fibroblasts.
Next, we constructed a laminectomy model in rats
and treated them with different concentrations of
RAPA, chosen on the basis of previous studies [37,
39]. We found that the local application of RAPA
inhibited fibroblast proliferation in epidural scar tis-
sues and reduced epidural fibrosis in rats. We evalu-
ated the effect of RAPA in reducing epidural fibrosis
by using several methods, including macroscopic
assessment of epidural fibrosis, evaluation of hydroxy-
proline content, histological analysis, and fibroblast
counting. The results indicated that the local
Fig. 6 After fibroblasts were cultured with different concentrations
of RAPA (0.01 μg/ml (b), 0.1 μg/ml (c), 1 μg/ml (d)) or control (a) for
48 h, the number of cells and cellular morphology were observed
under a light microscope. The magnification was ×400
Fig. 7 The expression levels of cleaved-PARP, Bax, and Bcl-2 in
fibroblasts after treatment with different concentrations of RAPA
(0.01 μg/ml, 0.1 μg/ml, and 1 μg/ml) for 48 h. When the dose of
RAPA increased, the levels of the pro-apoptotic proteins cleaved-PARP
and Bax increased; however, the levels of the anti-apoptotic protein
Bcl-2 decreased
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application of RAPA inhibited fibroblast proliferation
and reduced epidural fibrosis in a rat laminectomy
model without any signs of wound infection, neuro-
logical deficits or cerebrospinal leakage. Additionally,
0.2 mg/ml RAPA exhibited better effectiveness than did
lower concentrations of RAPA. Different concentra-
tions of RAPA reduced epidural adhesion in a dose-
dependent manner, except for the 0.05 mg/ml RAPA
group, which showed no difference compared with the
control group.
The results of this and previous studies show that
RAPA can reduce epidural scar adhesion. RAPA pre-
vents the progression of the cell cycle from G1 to S
phases in T-lymphocytes and other cell types through
various signal transduction pathways. It also inhibits
the proliferation of immune cells, including fibro-
blasts. RAPA binds to immunophilin FKBP12, which
blocks the nuclear factor of activated T-cells from en-
tering the nucleus, reduces the production of cyto-
kines such as IL-2 and alleviates the immune reaction
[40]. As the number of inflammatory cytokines de-
creases, the number of fibroblasts decreases. Add-
itionally, RAPA inhibits the expression of Bcl-2 in T-
lymphocytes and other cell types, including fibro-
blasts; thus, RAPA promotes fibroblast apoptosis and
accordingly decreases epidural fibrosis after laminec-
tomy [41].
Considering these results, we concluded that the
local application of RAPA may be an innovative and
safe treatment for reducing epidural fibrosis. To ac-
complish this effect, RAPA affects the activity of fi-
broblasts after the immune reaction is alleviated. The
present study is a preliminary assessment of the effect
of RAPA on decreasing epidural fibrosis, using histo-
logical and histomorphometric analysis. A higher dos-
age of RAPA may produce better results, and more
in-depth research on its mechanisms is still needed in
the future.
Conclusions
The local application of RAPA can reduce epidural
fibrosis after laminectomy by inhibiting the proliferation
of fibroblasts, stimulating their apoptosis, and decreasing
collagen synthesis. This protocol may be used in new
clinical treatment strategies to reduce epidural fibrosis
after laminectomy.
Fig. 8 The results of TUNEL staining after fibroblasts were treated with different concentrations of RAPA (0.01 μg/ml, 0.1 μg/ml, and 1 μg/ml) for 48 h
are shown. The nuclei of fibroblasts were stained with DAPI. After TUNEL staining, the nuclei of apoptotic fibroblasts were green. When the dose of
RAPA increased, the number of apoptotic nuclei increased. The images were observed using fluorescence microscopy. The magnification is ×400
Fig. 9 The percentages of TUNEL-positive cells in each group. Three
fields were counted to obtain the percentages of TUNEL-positive
cells in each group. *p < 0.05 compared with the control group
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